Biotransformation Pathways and Metabolite Profiles of Oral [(14)C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors
口服[(14)C]Alisertib (MLN8237)（一种在研的Aurora A激酶抑制剂）在晚期实体瘤患者中的生物转化途径和代谢物谱
期刊:Drug Metabolism and Disposition
影响因子:4
doi:10.1124/dmd.119.087338
Pusalkar, Sandeepraj; Zhou, Xiaofei; Li, Yuexian; Cohen, Lawrence; Yang, Jun Johnny; Balani, Suresh K; Xia, Cindy; Shyu, Wen Chyi; Lu, Chuang; Venkatakrishnan, Karthik; Chowdhury, Swapan K
